Planning Survey Questionnaire (PSQ)

Similar documents
CMS Unveils 12-Step Reconciliation Process For Retiree Drug Subsidy (RDS)

New Federal Early Retiree. Reinsurance Program

MEDICARE PLAN PAYMENT GROUP

MEDICARE PLAN PAYMENT GROUP

Retiree Drug Subsidy Update and RDS Program Oversight

The Second National Medicare Prescription Drug Congress

Contract Summary. OptumRx Administrative Services, LLC

Part D Administrative Contract Flowdowns

Answers to Frequently Asked Questions

First Tier Entity Attestation 2017 Medicare Advantage Organization (Sponsor) Compliance Program

REQUIREMENTS FOR THE EARLY RETIREE REINSURANCE PROGRAM

Implement a definition of negotiated price to include all pharmacy price concessions.

2019 Transition Policy

2018 Medicare Part D Transition Policy

FAQ Results. Date: 2/24/2010. Send To Printer. Question #8663: Are service fees included in the Average Sale Price (ASP) calculation?

Frequently Asked Questions Last Updated: November 16, 2015

Florida Agency for Health Care Administration AG Federal Awards Audit (Report# ) Six-Month Status Report as of September 30, 2014

2018 NEW GROUP APPLICATION

Medicare Part D Transition Policy CY 2018 HCSC Medicare Part D

Impact of H.R. 1038/S. 413 on CMS Payments Under Part D

PREMIUM IMPACT OF REMOVING MANUFACTURER REBATES FROM THE MEDICARE PART D PROGRAM

CENTERS FOR MEDICARE & MEDICAID SERVICES Creditable Coverage Disclosure to CMS Form Instructions and Screen Shots

CMS Releases Proposed Rule on Medicare Advantage and Medicare Prescription Drug Plan MLR Requirements. Jacinta L. Alves

San Francisco Health Service System Health Service Board

STATE OF LOUISIANA DIVISION OF ADMINISTRATION THE OFFICE OF GROUP BENEFITS (OGB) REQUEST FOR PROPOSALS (RFP) FOR

Ohio Public Employees Retirement System (OPERS) REQUEST FOR PROPOSAL (RFP)

Medicare and Prescription Drug Benefits. ABA Annual Meeting Section of Labor and Employment Law

Reporting and Disclosure Checklist for Welfare Benefit Plans

Unitarian Universalist Organizations Health Plan

Version Date 8/22/2013 UNIVERSITY OF ROCHESTER CLINICAL RESEARCH STANDARD OPERATING PROCEDURES REGARDING FINANCIAL OVERSIGHT AND BILLING COMPLIANCE

University of Nebraska at Omaha Service Center Procedure Appendix to Service Center Policy

Compliance and Fraud, Waste, and Abuse Awareness Training. First Tier, Downstream, and Related Entities

Health Care Reform at-a-glance

Self-Insurance Estimating Conference State Employees' Health Insurance Trust Fund Last conference held: July 26, 2007.

Medicare Part D: Retiree Drug Subsidy

Crime Coverage Section Application (Large Public Company > $1B revenues)

PREFERRED PHARMACY NETWORKS AND THEIR IMPACT ON PART D PREMIUMS

Values Accountability Integrity Service Excellence Innovation Collaboration

r Current BCBSIL clients

Texas Vendor Drug Program Pharmacy Provider Procedure Manual

2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:

HIV/AIDS Bureau, Division of Service Systems Monitoring Standards for Ryan White Part A and B Grantees: Part A Fiscal Monitoring Standards

2012 Checklist for Community Pharmacy. Medicare Part D-Related Information

SECTION I: General Employer Information. SECTION II: Division/Location Information

2012 Medicare Part D Transition Process for contracts H3864 & H4754:

Part II: Medicare Part C and Part D

Signature of company officer or authorized representative

RFP #16-BA121 HMO, PPO, and HSA/CDS Medical Programs Addendum 1 - Vendor Questions

Agent Medicare Sales ATRIO Health Plans Oversight

Claims Administrator Questionnaire

PHARMACY BENEFIT MANAGEMENT (PBM) SERVICES

Frequently asked questions and answers for pharmacy providers

Service Center Procedure Appendix to Service Center Policy

HIV/AIDS Bureau, Division of Metropolitan HIV/AIDS Programs National Monitoring Standards for Ryan White Part A Grantees: Fiscal Part A

GASB 45 and Medicare Part D: Understanding Your Liability and Potential Cash Subsidy

PROJECT SPECIFIC VENDOR QUESTIONNAIRE EMPLOYEE BENEFITS CONSULTING SERVICES

Overview of October 24, 2013 Final Rule on Program Integrity: Exchange, Premium Stabilization Programs, and Market Standards

This chapter sets forth the structure, implementation, and eligibility standards for the State

CMS Part D UPDATES. Kim Brandt Director, Program Integrity Centers for Medicare & Medicaid Services

TECHNICAL QUESTIONNAIRE - DENTAL PROPOSAL FORM TD1

Administrative Services Only (ASO) For Small Business Producer Communication #645 Issued October 3, 2013 Updated July 24, 2015

Retiree Exchange Frequently Asked Questions (FAQ)

Health Care Reform Update

STATE OF NEW JERSEY. SENATE, No th LEGISLATURE. Sponsored by: Senator NIA H. GILL District 34 (Essex and Passaic)

Southern Ohio Chamber Alliance Benefit Plan Producer Guide

IRS/SSA/CMS Data Match Guide on Instructions from CMS

Community Care, Inc. Medicare Part-D Enrollee Transition Plans H5212 PACE and H2034 HMO-SNP 2018

Required CMS Contract Clauses Revised 8/28/14 CMS MCM Guidance Chapter 21

Compliance Program. Health First Health Plans Medicare Parts C & D Training

Lehigh Valley Group Application

IMPACT OF THE ELIMINATION OF PREFERRED PHARMACY NETWORKS ON THE MEDICARE PART D PROGRAM

REINSTATEMENT And IMPLEMENTATION Of LAHIPP THIRD PARTY LIABILITY (TPL) CLAIMS PAYMENT

Continuation of the Prescription Drug Event (PDE) Reports and PDE Analysis Reporting Initiatives for the 2014 Benefit Year

Martin s Point Generations Advantage Policy and Procedure Form

Health Benefits Briefing

MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE. Reporting Requirements: Audit Preparedness for PDPs and Manufacturers

530: Accounts Payable Policy

A. GENERAL INFORMATION

Statutory-Basis Financial Statements and Supplementary Information and Independent Auditors' Report December 31, 2016 and 2015

1/6/2017. Surviving a CMS-Mandated Independent Validation Audit (IVA): 150 Days and Counting. Agenda. 150 Days and Counting

Surviving a CMS-Mandated Independent Validation Audit (IVA): 150 Days and Counting

TITLE 42 - THE PUBLIC HEALTH AND WELFARE CHAPTER 7 - SOCIAL SECURITY SUBCHAPTER XVIII - HEALTH INSURANCE FOR AGED AND DISABLED

Nexsure Training Manual - Accounting. Chapter 16

Texas Vendor Drug Program. Pharmacy Provider Procedure Manual Pricing & Reimbursement. Effective Date. March 2018

Medicare Plan Payment Group. Date: August 8, All Part D Plan Sponsors, including PACE Organizations

Frequently Asked Questions (FAQs) for First Tier, Downstream and Related Entities (FDRs)

Aon Hewitt 1. Why is CenturyLink changing the way retiree health insurance is delivered for those eligible for Medicare?

E-Commerce Enrollment

Annual Compliance Deadlines for Health Plans

American Bar Association. Technical Session Between the Department of Health and Human Services and the Joint Committee on Employee Benefits

I. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:

Ellie s Army Foundation

Pharmacy/Prescriber Medicaid Managed Care Network & Medicaid Provider Enrollment. February 14, 2018

American Bar Association. Technical Session Between the Centers for Medicare and Medicaid Services and the Joint Committee on Employee Benefits

Government Transaction Dispute Office Guide

Understanding the Bidding Process

Employer Group Waiver Plan (EGWP) FAQs

Session 108 L, Medicare Advantage MLR: Year Two. Moderator/Presenter: Scott O Neil Jones, FSA, MAAA

Contract Summary. OptumRx Administrative Services, LLC

6 KEY QUESTIONS TO ENSURE EFFECTIVE MANAGED CARE ADMINISTRATION AND OVERSIGHT

Transcription:

Planning Survey Questionnaire (PSQ) Plan Sponsor: LOCAL UNION Welfare Fund Benefit Plan Plan Sponsor ID#: XXXX Application ID#: XXXXX Complete this Survey for the applicable plan type and return it to the Auditor by the requested due date. Provide detailed responses where requested. Indicate "NA" when a question is not applicable to the Plan. When necessary, expand the document or attach a separate document as necessary. Note: The answers to the questions in this survey should be relevant to the RDS plan year ending in 2008 only unless otherwise specified. PART I: GENERAL INFORMATION 1) A. Briefly describe the current organizational structure, including related parties and joint ventures, if any. B. Was the Plan Sponsor a subsidiary or substantially owned by or controlled by another organization? C. Please provide a brief summary of the ownership and management structure of the organization. D. Have there been any changes in ownership such as mergers, purchases, etc.? If Yes, describe: E. Please provide a complete list of the Plan Sponsor s related parties. Related entity means any entity that is related to the Plan Sponsor by common ownership or control and (1) performs some of the RDS Plan Sponsor's management functions under contract or delegation; or (2) furnishes services to Medicare RDS qualifying covered retirees under an oral or written agreement. Related Party Name F. During the plan year under examination, did the Plan Sponsor receive any revenue from any related parties? If yes, please list the related organization and the type of income the Plan Sponsor receives, i.e. dividend, allocation, rebates, management fees, etc. Livanta, LLC Planning Survey Template November 2010 Page 1

Organization ATTACHMENT TO BENEFIT NEWS BRIEFS 2011-15 Type of Income G. Were there multiple applications for the Plan Sponsor? If yes, please list each application number, and Plan Sponsor identification number. Application Number Sponsor ID Number 2) A. Type of organization: Commercial Non-Profit Government Union Religious B. Form of entity: Corporation If public, ticker symbol LLC Sole Proprietorship Other (Explain) 3) How did you define benefit option(s)? 4) Was each benefit option fully insured or self funded? Benefit Option: Fully Insured or Self Funded Cost Reporter: Benefit Option: Fully Insured or Self Funded Cost Reporter: Benefit Option: Fully Insured or Self Funded Cost Reporter: 5) Have there been any instances of fraudulent activities/billings discovered for the plan year under audit as applies to RDS? If yes, please provide the detailed explanation and current status of such findings. 6) Were any changes made by the Plan Sponsor on the application from the initial application up to step 12 of the reconciliation process? Changes could include, but are not limited to, change of users, benefits, vendors, etc. If yes, provide details. Livanta, LLC Planning Survey Template November 2010 Page 2

7) Are you contemplating the filing of any appeals for reconsideration/reopening? If yes, describe the nature of the anticipated appeal. PART II: POLICIES, PROCEDURES & INTERNAL CONTROLS 8) Did the Plan Sponsor maintain written policy and procedures for the following transactions? Rebates and Similar Price Concessions Private Reinsurance Payment of Drug Claims Issuance of Notice of Credible Coverage Payment Request (RDS Subsidy) Process 9) For the plan year in 2008, were there any instances where access to Plan Sponsors or CMS systems was not terminated for associates no longer employed? If yes please describe. 10) A. Describe the policies and procedures implemented to comply with the 6 year record retention requirements (CFR 423.888(d)). B. Do the contracts with vendors include language regarding record retention? PART III: CREDITABLE COVERAGE NOTICES 11) List the names and contact information of the individuals who handled the Creditable Coverage Notice Disclosures for this Plan Year. Name Title Contact Info Name Title Contact Info PART IV: RETIREE FILES 12) Describe the Plan Sponsor s (and/or vendor s) process to ensure that only qualifying covered retirees costs were submitted for the RDS program. Livanta, LLC Planning Survey Template November 2010 Page 3

13) How did the Plan Sponsor determine the qualifying covered retirees were eligible to participate in the plan? 14) How did the Plan Sponsor validate the final covered retiree list received and agreed to in step 4 of reconciliation? 15) What are the Plan Sponsor s rules for determining whether the benefit option enrollee is retired or an active employee? 16) If the Plan Sponsor s vendor was responsible for creating and/or submitting retiree files, did the Plan Sponsor submit timely data to the vendor? If no, describe any problems noted by the vendor concerning timeliness? 17) A. Describe the procedures and process the Plan Sponsor implemented to ensure timely notification to CMS of any changes to the covered retiree file. B. Describe the procedures and process the Plan Sponsor implemented to ensure the Plan Sponsor s files were timely updated. 18) Who was responsible for processing retiree response and notification files received from the RDS Center? Name Title Organization 19) What controls did the Plan Sponsor establish over retiree eligibility information that was submitted to CMS by the vendor (if applicable)? 20) Are qualified covered retirees permitted to enroll into multiple benefit options? PART V: FINAL RECONCILIATION AND SUBMISSION OF COST DATA 21) Is the RDS plan year in the application the same as the plan year for other purposes, e.g. open enrollment, measuring deductibles, and 5500 Form reporting? If no, explain. Livanta, LLC Planning Survey Template November 2010 Page 4

22) Provide the name(s) and title(s) of the individual(s) who prepared the cost data that was submitted to the RDS program for each of the benefit options. Benefit Option Individual/Title/Organization 23) Provide the name(s) and title(s) of the individual(s) who submitted the cost data to the RDS program for each of the benefit options. Benefit Option Individual/Title/Organization 24) How did the Plan Sponsor (or vendor) determine whether drug costs were eligible for the RDS subsidy? 25) How did the Plan Sponsor (or vendor) identify and account for cost adjustments (manufacturer or pharmacy discounts, chargebacks, rebates, and/or other price concessions) when preparing cost data for submission to the RDS program? 26) A. Describe the process the Plan Sponsor implemented to validate the data for final reconciliation prior to submission to CMS by the Account Representative. B. Who performs this verification? Name Title 27) What controls did the Plan Sponsor establish over cost data that the vendor submitted to the RDS program on the Plan Sponsor's behalf (if applicable)? 28) For a fully insured benefit option, what procedures have been implemented to validate the costs from the insurance carrier? 29) Who reviewed and submitted the final reconciliation/payment request on behalf of the Plan Sponsor? Name Title 30) Are any amendments or corrections to final reconciliation reports anticipated? If yes, please describe. Livanta, LLC Planning Survey Template November 2010 Page 5

PART VI: PAYMENT REQUESTS, COST, AND PRICE CONCESSION RECORDS AND SYSTEMS 31) Describe the process for archiving RDS data inclusive of describing the ability to recreate a cost report. 32) Please explain the systems used to track the Group s Prescription Drug Plan related costs and activities and what processes were automated and/or manual. Expand as necessary. 33) Describe the systems for processing cost and claims including programs and applications utilized by the Plan Sponsor and its vendors. Please indicate the types of supporting documents for each system. 34) Were the journals, ledgers, and subsidiary ledgers that apply to the RDS plan year maintained electronically or manually? Journals Electronic Manual Ledgers Electronic Manual Sub-Ledgers Electronic Manual 35) Were the journals, ledgers, and subsidiary ledgers that apply to the RDS plan year available for review? Where are these journal ledgers located? Journals Location Ledgers Location Sub-Ledgers Location If not, please explain. Identify the physical location of accounting records. 36) Were supporting documents, such as invoices, billing statements, etc. available to verify the following transactions? General ledger transactions Subsidiary ledger transactions Journal entries Allocations 37) What process did the Plan Sponsor utilize to ensure its submitted costs to CMS were only for plan related Part D drugs for qualifying covered retirees? Livanta, LLC Planning Survey Template November 2010 Page 6

38) Describe how the Plan Sponsor recorded the transactions listed below in its general ledger. (Indicate account number, the process for recording the transactions, if subsidiary ledgers were used, and who recorded the transactions.) RDS Payments received Rebates (or other concessions on drug prices received) Insurance Premiums or Claims Payments 39) Describe the process the Plan Sponsor implemented to ensure: A. The accurate reporting of the threshold and limit reduction. B. The coordination of the threshold and limit reductions for qualified covered retirees enrolled in multiple benefit options, if applicable. 40) Were the costs reported to CMS the costs the PBM paid the Pharmacy, i.e. Pass-thru, or the costs paid to the PBM (if a PBM was used), i.e. Lock-in? 41) Is supporting documentation for the following available for review and where is it maintained? Transaction Supporting Documentation Location Prescription Drug Screen Shots of Yes No Data Transaction Enrollment Data Retiree Enrollment Records Yes No Rebates, Price Manufacturer/PBM Yes No Concessions, etc. contracts and/or agreements Please explain any No responses. Cost Adjustments -- Discounts, Chargebacks, Rebates, and Other Price Concessions 42) Who negotiated rebates and similar price concessions for Plan Sponsor's plan year ending 2008? Name Title Organization Livanta, LLC Planning Survey Template November 2010 Page 7

43) Who had the record keeping responsibility for the Plan Sponsor's rebates and similar price concessions? Name Title Organization 44) A.Were any price concessions remitted to the Plan Sponsor that originated from the manufacturer and/or the pharmacy? If yes, describe how the remittance of the price concessions was made to the Plan Sponsor. B. Were any price concessions remitted to the Plan Sponsor that did not originate from the manufacturer and/or pharmacy? If yes, from whom were they received and describe how the remittance for the price concessions were made to the Plan Sponsor. 45) Did the Plan Sponsor receive any reductions to drug costs, e.g. discounts, or other payments, that did not originate from a pharmacy or manufacturer? If yes, describe the type of payment and the process for recording the payment. 46) At what intervals did the Plan Sponsor receive rebates and similar price concessions (e.g., monthly, quarterly, year end, etc.)? 47) If the Plan Sponsor received interim subsidy payments and reported estimated cost adjustments, describe how the Plan Sponsor or vendor reconciled actual cost adjustments at final reconciliation. 48) Do the contracts negotiated by the party(s) noted in #42 above document the price concession terms? If yes, describe the terms. 49) Describe the process the Plan Sponsor used to validate the accuracy of all rebates and similar price concessions received. 50) Describe the Plan Sponsor s (or its vendor s) methodology and process for allocating rebates and similar price concessions to the various Plan Sponsor prescription drug plans (if applicable), and then to the benefit options, months, and/or drugs as it was reported to RDS. Livanta, LLC Planning Survey Template November 2010 Page 8

51) Were any rebates received after final reconciliation attributable to costs that were incurred during the RDS plan year? Comments Enter any comments, questions, or points of clarification in the space below. Completed By: Name (Print): Title/Position: Date: Livanta, LLC Planning Survey Template November 2010 Page 9